Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints... see more

NDAQ:APHA - Post Discussion

Aphria Inc. > Tilray's AB InBev and Norvartis deals are BullS h i t
View:
Post by ilvmyt5s on Dec 25, 2020 2:19am

Tilray's AB InBev and Norvartis deals are BullS h i t

Do you guys think Tilray's AB InBev and Norvartis deals are Bull S h i t and just PR to boost the SP?
Comment by DaveInCalgary on Dec 25, 2020 10:57am
https://www.businesswire.com/news/home/20181219005791/en/
Comment by DaveInCalgary on Dec 25, 2020 11:03am
https://www.sandoz.ca/en/news/media-releases/sandoz-canada-becomes-first-canadian-pharmaceutical-company-enter-medical
Comment by DaveInCalgary on Dec 25, 2020 11:03am
https://www.businesswire.com/news/home/20181218005141/en/Tilray%C2%AE-Signs-Global-Collaboration-Agreement-with-Leading-Pharmaceutical-Company
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities